Summit Rock Advisors, LP Diversified Active

Location: New York, NY

CIK: 0001540951 · Show all filings

Period: Q2 2020 (← Previous) (Next →)

Filing Date: Aug 10, 2020

Total Value: $107M (100.0% shares, 0.0% debt)

Holdings (5)

ACWI ISHARES TR 65.8%

Value $70.6M Shares 957,719 Share Price $73.72 Est. Cost/Share $71.28 Unrealized @ Report Date +3.4%

HYG ISHARES TR 13.8%

Value $14.77M Shares 180,999 Share Price $81.62 Est. Cost/Share $80.59 Unrealized @ Report Date +1.3%

VOO VANGUARD INDEX FDS 10.4%

Value $11.21M Shares 39,558 Share Price $283.43 Est. Cost/Share $269.16 Unrealized @ Report Date +5.3%

ICVT ISHARES TR 9.0%

Value $9.61M Shares 135,431 Share Price $70.96 Est. Cost/Share $63.53 Unrealized @ Report Date +11.7%

PHAT PHATHOM PHARMACEUTICALS INC 1.1%

Value $1.144M Shares 34,776 Share Price $32.90 Est. Cost/Share $38.42 Unrealized @ Report Date -14.3%

Ticker	Issuer	Shares	Value	%	Share Price	Est. Cost/Share	Unrealized @ Report Date	Class	CUSIP
ACWI	ISHARES TR	957,719	$70.6M	65.8%	$73.72	$71.28	+3.4%	MSCI ACWI ETF	464288257
HYG	ISHARES TR	180,999	$14.77M	13.8%	$81.62	$80.59	+1.3%	IBOXX HI YD ETF	464288513
VOO	VANGUARD INDEX FDS	39,558	$11.21M	10.4%	$283.43	$269.16	+5.3%	S&P 500 ETF SHS	922908363
ICVT	ISHARES TR	135,431	$9.61M	9.0%	$70.96	$63.53	+11.7%	CONV BD ETF	46435G102
PHAT	PHATHOM PHARMACEUTICALS INC	34,776	$1.144M	1.1%	$32.90	$38.42	-14.3%	COM	71722W107